The US life science instrumentation market is projected to grow at a significant CAGR of around 6.2% during the forecast period (2021-2027). The US is anticipated to be a major contributor to the growth of the life science instrumentation market. Significant funding for life science-related research in the country is a key factor contributing to the growth of the US life science instrumentation market. DNA sequencing technologies have emerged as efficient technology in the US as an alternative to treat numerous chronic diseases across the country. However, scientists consider the microbiome as the second genome and some even term it as one of the human body organs. Therefore, the increasing demand for these sequencing technologies further expand the adoption of life science instrumentation in the country.
Browse the full report description of "US Life Science Instrumentation Market Size, Share & Trends Analysis Report by Technology (Chromatography, Spectroscopy, Polymerase Chain Reaction (PCR), Clinical Chemistry Analyzers, Immunoassays, Next Generation Sequencing (NGS), Flow Cytometry, Microscopy, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, and Hospitals & Laboratories) and Forecast 2021-2027" at https://www.omrglobal.com/industry-reports/us-life-science-instrumentation-market
Moreover, growing cell culture research in the country further provides a significant opportunity to the life science instrumentation market in the region. The US is expected to register a significant share in the cell culture market due to the presence of major life science companies and increased R&D projects in cancer research. Cell culture is widely being used in the US biopharmaceutical industries for vaccine production, drug development, tissue culture, and engineering and the production of monoclonal antibodies and therapeutics for cancer. The US biopharmaceutical sector provides important R&D investments supporting new treatments and potential cures that improve the health and well?being of individuals. The biopharmaceutical sector sustains a large?scale supply chain—both in R&D and in support of the production and distribution of life science instrumentation products in the country.
Market Coverage
|
Report Elements |
Details |
|
Study Period |
2020-2027 |
|
Base year |
2020 |
|
Forecast period |
2021-2027 |
|
Segments Covered |
By Technology and by End-User |
|
Key Companies Profiled |
Agilent Technologies, Inc., Becton, Dickinson and Co., Bio-Rad
Laboratories,Inc.,Danaher Corp., Illumina, Inc., Thermo Fisher Scientific, Inc. and
others |
Key questions addressed by the report
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected segment
o Recommendations
US Life Science Instrumentation Market – Segmentation
By Technology
By End-User
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/us-life-science-instrumentation-market